FDA inspection
Amol Pharmaceuticals Private Ltd.: FDA inspection ending Feb 16, 2018
FDA inspection 1041368 · Voluntary Action Indicated (VAI) · Sitapura Industrial Area
Key facts
| Inspection ID | 1041368 |
|---|---|
| Firm | Amol Pharmaceuticals Private Ltd. |
| FEI number | 3003925108 |
| Address | E1 - 363 Sanganer |
| City | Sitapura Industrial Area |
| Country | India |
| Fiscal year | 2018 |
| Inspection end date | Feb 16, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data